Format

Send to

Choose Destination
Sci Rep. 2017 Apr 19;7(1):927. doi: 10.1038/s41598-017-01004-y.

In vivo dynamics of AAV-mediated gene delivery to sensory neurons of the trigeminal ganglia.

Author information

1
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
2
Department of Neuroscience, Columbia University, New York, NY, USA.
3
Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.
4
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. kjerome@fhcrc.org.
5
Department of Laboratory Medicine, University of Washington, Seattle, WA, USA. kjerome@fhcrc.org.
6
Department of Microbiology, University of Washington, Seattle, WA, USA. kjerome@fhcrc.org.

Abstract

The ability to genetically manipulate trigeminal ganglion (TG) neurons would be useful in the study of the craniofacial nervous system and latent alphaherpesvirus infections. We investigated adeno-associated virus (AAV) vectors for gene delivery to the TG after intradermal whiskerpad delivery in mice. We demonstrated that AAV vectors of serotypes 1, 7, 8, and 9 trafficked from the whiskerpad into TG neurons and expressed transgenes within cell bodies and axons of sensory neurons in all three branches of the TG. Gene expression was highest with AAV1, and steadily increased over time up to day 28. Both constitutive and neuronal-specific promoters were able to drive transgene expression in TG neurons. Levels of vector genomes in the TG increased with input dose, and multiple transgenes could be co-delivered to TG neurons by separate AAV vectors. In conclusion, AAV1 vectors are suitable for gene delivery to TG sensory neurons following intradermal whiskerpad injection.

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center